MJS719, & why not LL AAV for other diseases too, d
Post# of 148281
Others are working on AAV for certain diseases, but they still have the obvious -- side effect issues.
Dr. Sacha continues getting "provocative" results, i don't see how industry interests dosen't push LL beyond the HIV work.
But absolutely, finding combo(s) for LL & the future of "functional cure", could also see LL as a dominant drug baseline for R&D & frwd .......